• Je něco špatně v tomto záznamu ?

Novel mutations in xanthine dehydrogenase/oxidase cause severe hypouricemia: biochemical and molecular genetic analysis in two Czech families with xanthinuria type I

B. Stiburkova, J. Krijt, P. Vyletal, J. Bartl, E. Gerhatova, M. Korinek, I. Sebesta

. 2012 ; 413 (1-2) : 93-99.

Jazyk angličtina Země Nizozemsko

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12022181

BACKGROUND: The article describes the clinical, biochemical, enzymological and molecular genetics findings in two patients from two families with xanthinuria type I. METHODS: Biochemical analysis using high performance liquid chromatography, allopurinol loading test and analysis of xanthine oxidase activity in plasma and of uromodulin excretion in urine were performed. Sequencing analysis of the xanthine dehydrogenase gene and the haplotype and statistical analyses of consanguinity were performed. RESULTS: Probands showed extremely low concentrations of uric acid, on seven occasions under the limit of detection. The concentration of uric acid in 38-year-old female was 15 μmol/L in serum and 0.04 mmol/L in urine. Excretion of xanthine in urine was 170 mmol/mol creatinine. The concentration of uric acid in 25-year-old male was 0.03 mmol/L in urine. Excretion of xanthine in urine was 141 mmol/mol creatinine. The allopurinol loading test confirmed xanthinuria type I. The xanthine oxidase activities in patients were 0 and 0.4 pmol/h/mL of plasma. We found three nonsense changes: p.P214QfsX4 and unpublished p.R825X and p.R881X. CONCLUSIONS: We found two nonconsanguineous compound heterozygotes with xanthinuria type I caused by three nonsense changes. The methods used did not confirm consanguinity in the probands, thus there might be an unconfirmed biological relationship or mutational hotspot.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12022181
003      
CZ-PrNML
005      
20160215085949.0
007      
ta
008      
120806s2012 ne f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.cca.2011.08.038 $2 doi
035    __
$a (PubMed)21963464
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Stibůrková, Blanka, $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. bstib@lf1.cuni.cz $d 1970- $7 xx0056517
245    10
$a Novel mutations in xanthine dehydrogenase/oxidase cause severe hypouricemia: biochemical and molecular genetic analysis in two Czech families with xanthinuria type I / $c B. Stiburkova, J. Krijt, P. Vyletal, J. Bartl, E. Gerhatova, M. Korinek, I. Sebesta
520    9_
$a BACKGROUND: The article describes the clinical, biochemical, enzymological and molecular genetics findings in two patients from two families with xanthinuria type I. METHODS: Biochemical analysis using high performance liquid chromatography, allopurinol loading test and analysis of xanthine oxidase activity in plasma and of uromodulin excretion in urine were performed. Sequencing analysis of the xanthine dehydrogenase gene and the haplotype and statistical analyses of consanguinity were performed. RESULTS: Probands showed extremely low concentrations of uric acid, on seven occasions under the limit of detection. The concentration of uric acid in 38-year-old female was 15 μmol/L in serum and 0.04 mmol/L in urine. Excretion of xanthine in urine was 170 mmol/mol creatinine. The concentration of uric acid in 25-year-old male was 0.03 mmol/L in urine. Excretion of xanthine in urine was 141 mmol/mol creatinine. The allopurinol loading test confirmed xanthinuria type I. The xanthine oxidase activities in patients were 0 and 0.4 pmol/h/mL of plasma. We found three nonsense changes: p.P214QfsX4 and unpublished p.R825X and p.R881X. CONCLUSIONS: We found two nonconsanguineous compound heterozygotes with xanthinuria type I caused by three nonsense changes. The methods used did not confirm consanguinity in the probands, thus there might be an unconfirmed biological relationship or mutational hotspot.
650    _2
$a dospělí $7 D000328
650    _2
$a sekvence nukleotidů $7 D001483
650    _2
$a western blotting $7 D015153
650    _2
$a DNA primery $7 D017931
650    _2
$a elektroforéza v polyakrylamidovém gelu $7 D004591
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a haplotypy $7 D006239
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikrosatelitní repetice $7 D018895
650    _2
$a mutace $7 D009154
650    _2
$a kyselina močová $x krev $7 D014527
650    _2
$a xanthin $x moč $7 D019820
650    _2
$a xanthindehydrogenasa $x genetika $7 D014968
650    _2
$a xanthinoxidasa $x genetika $7 D014969
651    _2
$a Česká republika $7 D018153
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Krijt, Jakub, $d 1961- $7 jo2002159892 $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic
700    1_
$a Vyleťal, Petr $7 xx0119194 $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic; Center for Applied Genomics, First Faculty of Medicine, Charles University in Prague, Czech Republic
700    1_
$a Bártl, Josef $7 xx0232842
700    1_
$a Gerhátová, Eva $u GENERI BIOTECH, Hradec Kralove, Czech Republic
700    1_
$a Kořínek, Martin $u Institute of Social Work, University of Hradec Kralove, Czech Republic
700    1_
$a Šebesta, Ivan, $d 1959- $7 jo2003184053 $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague; Institute of Clinical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic
773    0_
$w MED00009464 $t Clinica chimica acta; international journal of clinical chemistry $x 1873-3492 $g Roč. 413, č. 1-2 (2012), s. 93-99
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21963464 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120806 $b ABA008
991    __
$a 20160215090131 $b ABA008
999    __
$a ok $b bmc $g 944094 $s 779478
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 413 $c 1-2 $d 93-99 $i 1873-3492 $m Clinica chimica acta $n Clin Chim Acta $x MED00009464
LZP    __
$b NLK111 $a Pubmed-20120806/12/01

Najít záznam

Citační ukazatele

Možnosti archivace